Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Preprandial Human Insulin With the AERx® iMS Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Asthma: A 52-week, Open-label, Multinational, Randomised, Parallel Trial to Investigate Long-term Safety

NCT00523042 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00523042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00523042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Preprandial Human Insulin With the AERx® iMS Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Asthma: A 52-week, Open-label, Multinational, Randomised, Parallel Trial to Investigate Long-term Safety
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Terminated
Start date
August 30, 2007
Completion date
February 28, 2008
Enrollment
10 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, diabetes, diabetes mellitus, type 1, diabetes mellitus, type 2